Loading...
Loading...
India's fluticasone imports from BELGIUM total $768 across 1 shipments from 1 foreign suppliers. IKRIS PHARMA INTERNATIONAL leads with $768 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include SAVA HEALTHCARE LIMITED. This corridor reflects India's pharmaceutical import demand for fluticasone โ a concentrated sourcing relationship with select suppliers from BELGIUM.

IKRIS PHARMA INTERNATIONAL is the leading Fluticasone supplier from BELGIUM to India, with import value of $768 across 1 shipments. The top 5 suppliers โ IKRIS PHARMA INTERNATIONAL โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IKRIS PHARMA INTERNATIONAL | $768 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SAVA HEALTHCARE LIMITED | $768 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Fluticasone suppliers from BELGIUM to India include IKRIS PHARMA INTERNATIONAL. The leading supplier is IKRIS PHARMA INTERNATIONAL with import value of $768 USD across 1 shipments. India imported Fluticasone worth $768 USD from BELGIUM in total across 1 shipments.
India imported Fluticasone worth $768 USD from BELGIUM across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Fluticasone sourced from BELGIUM include SAVA HEALTHCARE LIMITED. The largest buyer is SAVA HEALTHCARE LIMITED with $768 in imports across 1 shipments.
The total value of Fluticasone imports from BELGIUM to India is $768 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists